Clinical Trials Browser

Phase 3 × NIH × epratuzumab × Clear all

NCT00022685 2013-12-19

Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma

Phase 3 Unknown

Lymphoma, Lymphoma, Follicular